Electra Therapeutics Alternatives & Competitors
12 companies similar to Electra Therapeutics — A unique vision on mastering SIRP. A new way to change lives.
Companies similar to Electra Therapeutics
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
ZielBio, Inc.
Designing Solutions. Discovering Biology. Delivering Hope.
Charlottesville, United S...
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
Cambridge, United States
Track all Electra Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
Chemomab Therapeutics
Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation...
Israel
Vor Bio
Vor Bio's vision is to cure blood cancers through cell and genome engineering.
Cambridge, United States
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
San Carlos, United States
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Evelo Biosciences
Clinical stage biotech company developing a new modality of oral biologics that act on cel...
Cambridge, United States
Passage Bio
Our mission is to improve the lives of patients with neurodegenerative diseases
Philadelphia, United Stat...
About Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company founded in 2018. They specialize in developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Their recent milestone includes an impressive $84.00M Series B investment on 16 February 2022.
Clinical Stage, Therapeutics, SIRP Targeting Therapies, Immunological Diseases, Cancer Treatment, ELA026, Monoclonal Antibody, Myeloid Cells, T Cells, SHLH, Hyperinflammatory Condition, Clinical Development, Preclinical Programs, Signal Regulatory Proteins
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Electra Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Electra Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
